Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tongtong Meng
Institutions:
Capital Medical University,
National Clinical Research Center for Digestive Diseases,
Beijing Friendship Hospital
Observed institutions:
Capital Medical University,
National Clinical Research Center for Digestive Diseases,
Beijing Friendship Hospital
ORCID:
0009-0002-4746-3662
Observed ORCID:
0009-0002-4746-3662
OpenAlex ID:
A5010037620
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
2020
·
Yameng Sun
, Xiaoning Wu
, et al.
·
Clinical Gastroenterology and Hepatology
·
154
PDF
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
2023
·
Yameng Sun
, Wei Chen
, et al.
·
Clinical Gastroenterology and Hepatology
·
34
Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B
2021
·
Shuyan Chen
, Jialing Zhou
, et al.
·
Hepatology International
·
25
Risk of Transmitting Coronavirus Disease 2019 During Nebulizer Treatment: A Systematic Review
2021
·
Karen M. Goldstein
, Kamrouz Ghadimi
, et al.
·
Journal of Aerosol Medicine and Pulmonary Drug Delivery
·
24
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis
2021
·
Xiaoning Wu
, Jia Hong
, et al.
·
Hepatology International
·
19
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
2019
·
Xiaoning Wu
, Jialing Zhou
, et al.
·
Infection and Drug Resistance
·
19
PDF
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
2023
·
Xiaoning Wu
, Xiaoqian Xu
, et al.
·
Clinical and Molecular Hepatology
·
16
PDF
Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China
2025
·
You Deng
, Tongtong Meng
, et al.
·
Journal of Clinical and Translational Hepatology
·
13
PDF
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease
2022
·
Yuanyuan Kong
, Tingting Lv
, et al.
·
Hepatology International
·
10
PDF
Seroepidemiology of hepatitis C virus infection in people aged 1–69 years in China: a national, cross-sectional study
2025
·
Jian Li
, Lin Pang
, et al.
·
The Lancet Public Health
·
9
PDF
Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment
2025
·
Mengyang Zhang
, Shuyan Chen
, et al.
·
Nature Communications
·
9
PDF
Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval
2024
·
Xiaoqian Xu
, Tongtong Meng
, et al.
·
Journal of Autoimmunity
·
9
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
2024
·
Shuyan Chen
, Jialing Zhou
, et al.
·
Hepatology International
·
9
A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti‐HBV therapy
2023
·
Shuyan Chen
, Bingqiong Wang
, et al.
·
Journal of Medical Virology
·
9
PDF
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy
2021
·
Xiaoning Wu
, Jialing Zhou
, et al.
·
Hepatology International
·
9
Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial
2023
·
Bingqiong Wang
, Jialing Zhou
, et al.
·
The American Journal of Gastroenterology
·
8
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis
2025
·
Yameng Sun
, Shuyan Chen
, et al.
·
Hepatology
·
6
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-Treatment Patients With Chronic Hepatitis B
2025
·
Xiaoning Wu
, Jialing Zhou
, et al.
·
Clinical Gastroenterology and Hepatology
·
3
Multiple Low‐Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy
2024
·
Zhengzhao Lu
, Ya‐Meng Sun
, et al.
·
Journal of Viral Hepatitis
·
3
PDF
Impact of hepatitis B surface antigen quantification on achieving a functional cure in patients with chronic hepatitis B: A systematic review and meta-analysis
2025
·
Shun Li
, Lichen Shi
, et al.
·
Annals of Hepatology
·
2
PDF
Burden of liver fibrosis and steatosis coexisting with hepatitis B or C infection in China: a population-based study from the 2020 National Serological Survey
2026
·
Tongtong Meng
, Yu Wang
, et al.
·
Gut
Exploratory analysis of transcriptionally active HBV-host chimeric transcript burden in patients with increasing HBsAg during long-term antiviral therapy
2026
·
Luqi Tang
, Bingqiong Wang
, et al.
·
Hepatology International
PDF
Dynamic changes in controlled attenuation parameter (CAP) improve prognostic prediction for CHB patients with significant fibrosis and cirrhosis
2026
·
Xiaowei Ai
, Mengyang Zhang
, et al.
·
Hepatology International
Show more works
View as search
Works count:
23
Citation count:
390
H-index:
9
I10-index:
9
Year
Topic
Type